Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Ischemic Heart Disease

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 59 articles: HTML format Text format

Single Articles

August 2019
1. FRANCHI F, Rollini F, Garcia E, Rivas Rios J, et al
   Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.
   Thromb Haemost. 2019 Aug 30. doi: 10.1055/s-0039-1695772.
   PubMed     Text format     Abstract available
   
   
   
2. ADATIA K, Farag MF, Gue YX, Srinivasan M, et al
   Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.
   Thromb Haemost. 2019 Aug 22. doi: 10.1055/s-0039-1695007.
   PubMed     Text format     Abstract available
   
   
   
3. PATTI G, Di Martino G, Ricci F, Renda G, et al
   Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study.
   Thromb Haemost. 2019 Aug 20. doi: 10.1055/s-0039-1694969.
   PubMed     Text format     Abstract available
   
   
   
4. STOJKOVIC S, Nossent AY, Haller P, Jager B, et al
   MicroRNAs as Regulators and Biomarkers of Platelet Function and Activity in Coronary Artery Disease.
   Thromb Haemost. 2019 Aug 17. doi: 10.1055/s-0039-1693702.
   PubMed     Text format     Abstract available
   
   
   July 2019
5. KAIKITA K, Hosokawa K, Dahlen JR, Tsujita K, et al
   Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease.
   Thromb Haemost. 2019 Jul 22. doi: 10.1055/s-0039-1693411.
   PubMed     Text format     Abstract available
   
   
   
6. KOENEN RR
   Lysophosphatidylcholine in Platelet Microvesicles: The Grease for Cardiovascular Disease.
   Thromb Haemost. 2019 Jul 2. doi: 10.1055/s-0039-1693024.
   PubMed     Text format    
   
   
   June 2019
7. FIECHTER M, Haider A, Bengs S, Maredziak M, et al
   Sex Differences in the Association between Inflammation and Ischemic Heart Disease.
   Thromb Haemost. 2019 Jun 21. doi: 10.1055/s-0039-1692442.
   PubMed     Text format     Abstract available
   
   
   
8. GROSS L, Kupka D, Trenk D, Geisler T, et al
   Gender and Outcomes following Guided De-Escalation of Antiplatelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Gender Substudy.
   Thromb Haemost. 2019 Jun 21. doi: 10.1055/s-0039-1692441.
   PubMed     Text format     Abstract available
   
   
   
9. SEJRUP JK, Borvik T, Grimnes G, Isaksen T, et al
   Myocardial Infarction as a Transient Risk Factor for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study.
   Thromb Haemost. 2019 Jun 16. doi: 10.1055/s-0039-1692176.
   PubMed     Text format     Abstract available
   
   
   May 2019
10. UBAID S, Ford TJ, Berry C, Murray HM, et al
    Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial.
    Thromb Haemost. 2019 May 26. doi: 10.1055/s-0039-1688789.
    PubMed     Text format     Abstract available
    
    
    
11. KANG J, Park KW, Ki YJ, Park J, et al
    Development and Validation of an Ischemic and Bleeding Risk Evaluation Tool in East Asian Patients Receiving Percutaneous Coronary Intervention.
    Thromb Haemost. 2019 May 12. doi: 10.1055/s-0039-1688792.
    PubMed     Text format     Abstract available
    
    
    March 2019
12. SUMAYA W, Geisler T, Kristensen SD, Storey RF, et al
    Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?
    Thromb Haemost. 2019 Mar 5. doi: 10.1055/s-0039-1679903.
    PubMed     Text format     Abstract available
    
    
    
13. ZHENG YY, Wu TT, Chen Y, Hou XG, et al
    Gamma-Glutamyl Transferase-to-Platelet Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Thromb Haemost. 2019 Mar 1. doi: 10.1055/s-0039-1681103.
    PubMed     Text format     Abstract available
    
    
    February 2019
14. GENCER S, van der Vorst EPC, Aslani M, Weber C, et al
    Atypical Chemokine Receptors in Cardiovascular Disease.
    Thromb Haemost. 2019 Feb 4. doi: 10.1055/s-0038-1676988.
    PubMed     Text format     Abstract available
    
    
    
15. MARTINELLI N, Baroni M, Castagna A, Lunghi B, et al
    Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation.
    Thromb Haemost. 2019;119:192-202.
    PubMed     Text format     Abstract available
    
    
    January 2019
16. FREYNHOFER MK, Hein-Rothweiler R, Haller PM, Aradi D, et al
    Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study.
    Thromb Haemost. 2019 Jan 29. doi: 10.1055/s-0038-1677549.
    PubMed     Text format     Abstract available
    
    
    
17. KOH JS, Park Y, Ahn JH, Kang MG, et al
    Influence of Amlodipine on Haemostatic Measurements during Clopidogrel Treatment in Patients with Coronary Artery Disease.
    Thromb Haemost. 2019 Jan 4. doi: 10.1055/s-0038-1676795.
    PubMed     Text format     Abstract available
    
    
    
18. PACIULLO F, Momi S, Gresele P
    PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention.
    Thromb Haemost. 2019 Jan 3. doi: 10.1055/s-0038-1676863.
    PubMed     Text format     Abstract available
    
    
    
19. LEADER A, Ten Cate V, Ten Cate-Hoek AJ, Spectre G, et al
    Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based Experiment.
    Thromb Haemost. 2019;119:163-174.
    PubMed     Text format     Abstract available
    
    
    
20. KANG J, Park KW, Palmerini T, Stone GW, et al
    Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs.
    Thromb Haemost. 2019;119:149-162.
    PubMed     Text format     Abstract available
    
    
    December 2018
21. TSCHARRE M, Vogel B, Tentzeris I, Freynhofer MK, et al
    Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Dec 28. doi: 10.1055/s-0038-1676563.
    PubMed     Text format     Abstract available
    
    
    November 2018
22. SIKORA J, Niezgoda P, Baranska M, Buszko K, et al
    METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS-The METAMORPHOSIS Trial.
    Thromb Haemost. 2018 Nov 19. doi: 10.1055/s-0038-1675605.
    PubMed     Text format     Abstract available
    
    
    
23. STEENSIG K, Olesen KKW, Thim T, Nielsen JC, et al
    Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.
    Thromb Haemost. 2018 Nov 12. doi: 10.1055/s-0038-1675401.
    PubMed     Text format     Abstract available
    
    
    
24. KRUGER PC, Hirsh J, Bhagirath VC, Xu K, et al
    In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets.
    Thromb Haemost. 2018;118:1895-1901.
    PubMed     Text format     Abstract available
    
    
    October 2018
25. BADIMON L
    Monocyte-Platelet Complexes in Myocardial Infarction: Sub-Sets and Platelet-Derived Microvesicles Matter.
    Thromb Haemost. 2018 Oct 17. doi: 10.1055/s-0038-1675242.
    PubMed     Text format    
    
    
    
26. SORRENTINO S, Baber U, Claessen BE, Camaj A, et al
    Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Oct 12. doi: 10.1055/s-0038-1673687.
    PubMed     Text format     Abstract available
    
    
    
27. LOGUINOVA M, Pinegina N, Kogan V, Vagida M, et al
    Monocytes of Different Subsets in Complexes with Platelets in Patients with Myocardial Infarction.
    Thromb Haemost. 2018 Oct 9. doi: 10.1055/s-0038-1673342.
    PubMed     Text format     Abstract available
    
    
    September 2018
28. BONELLO L, Laine M, Lemesle G, Puymirat E, et al
    Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease.
    Thromb Haemost. 2018 Sep 20. doi: 10.1055/s-0038-1669426.
    PubMed     Text format     Abstract available
    
    
    
29. HANNAWI B, Hannawi Y, Kleiman NS
    Reticulated Platelets: Changing Focus from Basics to Outcomes.
    Thromb Haemost. 2018;118:1517-1527.
    PubMed     Text format     Abstract available
    
    
    August 2018
30. ZEYMER U, Schrage B, Westermann D
    Dual Pathway Inhibition with Low-Dose Direct Factor Xa Inhibition after Acute Coronary Syndromes-Why Is It Not Used in Clinical Practice?
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1668133.
    PubMed     Text format     Abstract available
    
    
    
31. KARHAUSEN JA, Qi W, Smeltz AM, Li YJ, et al
    Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia after Coronary Artery Bypass Surgery.
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667199.
    PubMed     Text format     Abstract available
    
    
    
32. GROSS L, Trenk D, Jacobshagen C, Krieg A, et al
    Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping Substudy.
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667337.
    PubMed     Text format     Abstract available
    
    
    
33. DUERSCHMIED D, Bode C
    Life-Saving Therapy versus Symptom Relief: Anti-Platelet Agents and Opioids in Coronary Intervention.
    Thromb Haemost. 2018;118:1350-1351.
    PubMed     Text format    
    
    
    July 2018
34. PEDICINO D, Giglio AF, Ruggio A, Massaro G, et al
    Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives.
    Thromb Haemost. 2018 Jul 10. doi: 10.1055/s-0038-1666860.
    PubMed     Text format     Abstract available
    
    
    June 2018
35. COELHO-LIMA J, Mohammed A, Cormack S, Jones S, et al
    Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction.
    Thromb Haemost. 2018 Jun 11. doi: 10.1055/s-0038-1660437.
    PubMed     Text format     Abstract available
    
    
    
36. ZAKAI NA, Judd SE, Kissela B, Howard G, et al
    Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS).
    Thromb Haemost. 2018 Jun 11. doi: 10.1055/s-0038-1655766.
    PubMed     Text format     Abstract available
    
    
    
37. VAN DER VORST EPC, Weber C, Donners MMPC
    A Disintegrin and Metalloproteases (ADAMs) in Cardiovascular, Metabolic and Inflammatory Diseases: Aspects for Theranostic Approaches.
    Thromb Haemost. 2018 Jun 6. doi: 10.1055/s-0038-1660479.
    PubMed     Text format     Abstract available
    
    
    
38. SUMAYA W, Parker WAE, Fretwell R, Hall IR, et al
    Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study).
    Thromb Haemost. 2018 Jun 6. doi: 10.1055/s-0038-1657768.
    PubMed     Text format     Abstract available
    
    
    
39. ALEXOPOULOS D, Xenogiannis I, Vlachakis P, Tantry U, et al
    Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Jun 4. doi: 10.1055/s-0038-1649484.
    PubMed     Text format     Abstract available
    
    
    
40. CAPODANNO D, Greco A
    Risk Stratification for Bleeding in the Elderly with Acute Coronary Syndrome: Not So Simple.
    Thromb Haemost. 2018;118:949-952.
    PubMed     Text format    
    
    
    May 2018
41. BATUCA JR, Amaral MC, Favas C, Justino GC, et al
    Antibodies against HDL Components in Ischaemic Stroke and Coronary Artery Disease.
    Thromb Haemost. 2018 May 3. doi: 10.1055/s-0038-1645857.
    PubMed     Text format     Abstract available
    
    
    April 2018
42. PERTIWI KR, van der Wal AC, Pabittei DR, Mackaaij C, et al
    Neutrophil Extracellular Traps Participate in All Different Types of Thrombotic and Haemorrhagic Complications of Coronary Atherosclerosis.
    Thromb Haemost. 2018 Apr 19. doi: 10.1055/s-0038-1641749.
    PubMed     Text format     Abstract available
    
    
    
43. MAHLA E, Metzler H, Bornemann-Cimenti H, Prueller F, et al
    Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
    Thromb Haemost. 2018 Apr 6. doi: 10.1055/s-0038-1641153.
    PubMed     Text format     Abstract available
    
    
    
44. GARAY A, Ariza-Sole A, Formiga F, Raposeiras-Roubin S, et al
    Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry.
    Thromb Haemost. 2018 Apr 3. doi: 10.1055/s-0038-1635259.
    PubMed     Text format     Abstract available
    
    
    March 2018
45. CAMM AJ
    The Evolution of Antithrombotic Care in Cardiovascular Patients.
    Thromb Haemost. 2018 Mar 22. doi: 10.1055/s-0038-1626720.
    PubMed     Text format    
    
    
    
46. KANG J, Han JK, Ahn Y, Chae SC, et al
    Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre Study.
    Thromb Haemost. 2018;118:591-600.
    PubMed     Text format     Abstract available
    
    
    
47. ARIZA-SOLE A, Guerrero C, Formiga F, Aboal J, et al
    Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry.
    Thromb Haemost. 2018;118:581-590.
    PubMed     Text format     Abstract available
    
    
    February 2018
48. MJELVA OR, Svingen GFT, Pedersen EKR, Seifert R, et al
    Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease.
    Thromb Haemost. 2018 Feb 19. doi: 10.1055/s-0038-1629912.
    PubMed     Text format     Abstract available
    
    
    
49. DE CARVALHO LP, Fong A, Troughton R, Yan BP, et al
    Prognostic Implications of Dual Platelet Reactivity Testing in Acute Coronary Syndrome.
    Thromb Haemost. 2018;118:415-426.
    PubMed     Text format     Abstract available
    
    
    
50. STOREY RF, Ardissino D, Vignali L, Cairns R, et al
    Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study.
    Thromb Haemost. 2018;118:427-429.
    PubMed     Text format    
    
    
    
51. STRATZ C, Nuhrenberg T, Valina CM, Loffelhardt N, et al
    Impact of Reticulated Platelets on the Antiplatelet Effect of the Intravenous P2Y12-Receptor Inhibitor Cangrelor.
    Thromb Haemost. 2018;118:362-368.
    PubMed     Text format     Abstract available
    
    
    January 2018
52. VON KANEL R, Meister-Langraf RE, Schmid JP, Barth J, et al
    Low Self-rated Health Is Related to Blood Hypercoagulability in Patients Admitted with Acute Myocardial Infarction.
    Thromb Haemost. 2018;118:54-62.
    PubMed     Text format     Abstract available
    
    
    
53. BURNLEY-HALL N, Abdul F, Androshchuk V, Morris K, et al
    Dietary Nitrate Supplementation Reduces Circulating Platelet-Derived Extracellular Vesicles in Coronary Artery Disease Patients on Clopidogrel Therapy: A Randomised, Double-Blind, Placebo-Controlled Study.
    Thromb Haemost. 2018;118:112-122.
    PubMed     Text format     Abstract available
    
    
    
54. LOWE GDO
    Self-related Health and Blood Hypercoagulability: A Possible Mechanism for Cardiovascular Risk.
    Thromb Haemost. 2018;118:4-5.
    PubMed     Text format    
    
    
    February 2017
55. ZEYMER U, Hohlfeld T, Vom Dahl J, Erbel R, et al
    Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE).
    Thromb Haemost. 2017;117:625-635.
    PubMed     Text format     Abstract available
    
    
    
56. CHRISTOPOULOS C, Farag M, Sullivan K, Wellsted D, et al
    Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.
    Thromb Haemost. 2017;117:457-470.
    PubMed     Text format     Abstract available
    
    
    
57. BIANCARI F, Brascia D, Onorati F, Reichart D, et al
    Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score.
    Thromb Haemost. 2017;117:445-456.
    PubMed     Text format     Abstract available
    
    
    January 2017
58. CHATTERJEE M, Behrendt A, Schmid M, Beck S, et al
    Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
    Thromb Haemost. 2017;117:311-324.
    PubMed     Text format     Abstract available
    
    
    November 2016
59. CHATTERJEE S, Weinberg I, Yeh RW, Chakraborty A, et al
    Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score.
    Thromb Haemost. 2016.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: